Please enter your details to request more information

Image

INVEST WITH

New revolutionary cancer treatment is set to transform global healthcare

Image

10.3X TARGET RETURNS

INCLUDING EIS TAX RELIEF

Image

HMRC EIS APPROVED

ImageImage

10.3x TARGET RETURNS

EXPERTISE IN KEY FIELDS

GET MORE INFORMATION
Image
  • HMRC EIS Approved with 30% Income Tax Relief
  • 10.3x Target returns including EIS Tax Relief
  • A management team with unmatched levels of expertise in key fields.
  • £24.8m Conservative Growth Profit Forecast - 2029.
  • The global breast cancer diagnostics market alone is expected to reach over USD 9.00 billion by 2033. That’s a CAGR of 7.2%
  • 1 in 8 women will develop breast cancer in their lifetime. *

Investment Highlights

GET MORE INFORMATION
Image

Frontier Diagnostics are improving the survival rates of cancer patients and increasing their quality of life by using new revolutionary early detection techniques, Ai-driven tools, genomic insights, and precision medicine.

‘ By quantifying circulating tumour cells (CTCs), we can identify early tumour activity in patients. The quantification of CTCs allows us to predict the effectiveness of a chemotherapeutic agent in percentage terms before it is even administered. That means we know how many cells will be killed in each round of therapy. We are developing a new platform-based solution to CTC cell counting for routine medical diagnostics. ’

Dr. Martin Burow CEO, The former Head of Asia Pacific for Thermo Fisher

Management Team

ImageImageImageImage
GET MORE INFORMATION

** https://amp.cancer.org

To be able to deal with your enquiry effectively we will need to contact you via telephone and/or email. By enquiring you consent to being contacted and you consent to your data being stored in accordance with European GDPR regulations. Privacy Policy


Disclaimer: Any person accessing this website or page and considering potential investment opportunities featured here, should make their own commercial assessment of an investment opportunity after seeking the advice of an appropriately authorised or regulated financial advisor. This website or page should not be construed as advice or a personal recommendation to any prospective investor. Investments of this nature carry risks to your capital and can go up or down. Past performance is not indicative of future results. Suitable appropriately qualified investors, sophisticated and high net worth investors only.